Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents

US Patent 9662321 · Granted May 30, 2017

Estimated economic value: $485,113,000

Assignee

Inventors

View full patent text on Google Patents →